Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Pitroda

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 15, 2022
Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular CarcinomaAditya Juloori, Rohan R Katipally, Jeffrey M Lemons, et al.
Plos One|June 9, 2009
STAT1 pathway mediates amplification of metastatic potential and resistance to therapyNikolai N Khodarev, Paul Roach, Sean P Pitroda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2024
Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal SitesYuzhu Hou, Kaiting Yang, Liangliang Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2021
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC StudyChristine M Bestvina, Kelli B Pointer, Theodore Karrison, et al.
Oncotarget|February 18, 2015
14q32-encoded microRNAs mediate an oligometastatic phenotypeAbhineet Uppal, Sean C Wightman, Stephen Mallon, et al.
Plos One|October 12, 2012
Tumor endothelial inflammation predicts clinical outcome in diverse human cancersSean P Pitroda, Tong Zhou, Randy F Sweis, et al.
NPJ Precision Oncology|October 14, 2022
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapyLiam F Spurr, Carlos A Martinez, Rohan R Katipally, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2014
RIG-I-like receptor LGP2 protects tumor cells from ionizing radiationRyan C Widau, Akash D Parekh, Mark C Ranck, et al.
Science Translational Medicine|February 25, 2021
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunityYuzhu Hou, Hua L Liang, Xinshuang Yu, et al.
Nature|November 10, 2025
Publisher Correction: Radiation-induced amphiregulin drives tumour metastasisAndrás Piffkó, Kaiting Yang, Arpit Panda, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|September 15, 2022
Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular CarcinomaAditya Juloori, Rohan R Katipally, Jeffrey M Lemons, et al.
Plos One|June 9, 2009
STAT1 pathway mediates amplification of metastatic potential and resistance to therapyNikolai N Khodarev, Paul Roach, Sean P Pitroda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2024
Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal SitesYuzhu Hou, Kaiting Yang, Liangliang Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2021
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC StudyChristine M Bestvina, Kelli B Pointer, Theodore Karrison, et al.
Oncotarget|February 18, 2015
14q32-encoded microRNAs mediate an oligometastatic phenotypeAbhineet Uppal, Sean C Wightman, Stephen Mallon, et al.
Plos One|October 12, 2012
Tumor endothelial inflammation predicts clinical outcome in diverse human cancersSean P Pitroda, Tong Zhou, Randy F Sweis, et al.
NPJ Precision Oncology|October 14, 2022
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapyLiam F Spurr, Carlos A Martinez, Rohan R Katipally, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2014
RIG-I-like receptor LGP2 protects tumor cells from ionizing radiationRyan C Widau, Akash D Parekh, Mark C Ranck, et al.
Science Translational Medicine|February 25, 2021
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunityYuzhu Hou, Hua L Liang, Xinshuang Yu, et al.
Nature|November 10, 2025
Publisher Correction: Radiation-induced amphiregulin drives tumour metastasisAndrás Piffkó, Kaiting Yang, Arpit Panda, et al.
Pageof 9